
Reset all filters
01 2Bylvay
Main Therapeutic Indication : Rare Diseases
Currency : USD
2023 Revenue in Millions : 80
2022 Revenue in Millions : 0
Growth (%) : Acquired from Albireo
Main Therapeutic Indication : Rare Diseases and Disorders
Currency : USD
2024 Revenue in Millions : 141
2023 Revenue in Millions : 80
Growth (%) : 77